Femasys (FEMY) Capital Expenditures (2020 - 2026)
Femasys (FEMY) posted Capital Expenditures of $79138.0 for Q1 2026, down 43.41% on a QoQ basis from $139840.0 in Q4 2025, and down 18.08% year-over-year from $96605.0 in Q1 2025.
Femasys (FEMY) Capital Expenditures (2020 - 2026) Analysis & Trends
Femasys' Capital Expenditures history runs 7 years deep, the most recent figure standing at $79138.0 for Q1 2026.
- Quarterly Capital Expenditures fell 18.08% year-over-year to $79138.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $507540.0 (down 36.06% YoY) and the FY2025 annual result came in at $525007.0, down 31.07% from the prior year.
- Capital Expenditures was $79138.0 for Q1 2026 at Femasys, down from $139840.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $407936.0 in Q3 2024 and bottomed at $8901.0 in Q1 2023.
- A 5-year average of $112779.0 and a median of $94229.0 in 2025 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures slumped 92.61% — and 2024, when it jumped 1401.48%.
- Femasys' Capital Expenditures stood at $93877.0 in 2022, then sank by 52.17% to $44899.0 in 2023, then jumped by 137.85% to $106792.0 in 2024, then jumped by 30.95% to $139840.0 in 2025, then slumped by 43.41% to $79138.0 in 2026.
- Business Quant data shows FEMY's Capital Expenditures at $79138.0 in Q1 2026, $139840.0 in Q4 2025, and $194333.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -139.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -34.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 125.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 33.65 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 86.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 84.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 30.79 Mn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - | 79,138.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79,138.00 |
| Mar 31, 2026 | 79,138.00 |
| Dec 31, 2025 | 139,840.00 |
| Dec 31, 2025 | 139,840.00 |
| Sep 30, 2025 | 194,333.00 |
| Sep 30, 2025 | 194,333.00 |
| Jun 30, 2025 | 94,229.00 |
| Jun 30, 2025 | 94,229.00 |
| Mar 31, 2025 | 96,605.00 |
| Mar 31, 2025 | 96,605.00 |
| Dec 31, 2024 | 106,792.00 |
| Dec 31, 2024 | 106,792.00 |
| Sep 30, 2024 | 407,936.00 |
| Sep 30, 2024 | 407,936.00 |
| Jun 30, 2024 | 182,421.00 |
| Jun 30, 2024 | 182,421.00 |
| Mar 31, 2024 | 64,557.00 |
| Mar 31, 2024 | 64,557.00 |
| Dec 31, 2023 | 44,899.00 |
| Dec 31, 2023 | 44,899.00 |